EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Selective androgen receptor modulators in preclinical and clinical development

Ramesh Narayanan, Michael L Mohler, Casey E Bohl, Duane D Miller, James T Dalton

Nuclear Receptor Signaling · 2008-01 · 6 (1)

DOI: 10.1621/nrs.06010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nuclear Receptor Signaling, online erschienen am 26.11.2008. Verfasst von Ramesh Narayanan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Preclinical Research and Development, GTx, Inc., Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Drug Design. Die Arbeit wurde bisher 129-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgen receptor (AR) plays a critical role in the function of several organs including primary and accessory sexual organs, skeletal muscle, and bone, making it a desirable therapeutic target. Selective androgen receptor modulators (SARMs) bind to the AR and demonstrate osteo- and myo-anabolic activity; however, unlike testosterone and other anabolic steroids, these nonsteroidal agents produce less of a growth effect on prostate and other secondary sexual organs. SARMs provide therapeutic opportunities in a variety of diseases, including muscle wasting associated with burns, cancer, or end-stage renal disease, osteoporosis, frailty, and hypogonadism. This review summarizes the current standing of research and development of SARMs, crystallography of AR with SARMs, plausible mechanisms for their action and the potential therapeutic indications for this emerging class of drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignAnimalsClinical Trials as TopicDrug Evaluation, PreclinicalHumansReceptors, Androgen

Substanzen

Receptors, Androgen

Autor:innen und Institutionen

  • Preclinical Research and Development, GTx, Inc., Memphis, Tennessee, USA.

Zitieren

APA

Narayanan, R., Mohler, M. L., Bohl, C. E., Miller, D. D., & Dalton, J. T. (2008). Selective androgen receptor modulators in preclinical and clinical development. Nuclear Receptor Signaling, 6(1). https://doi.org/10.1621/nrs.06010

Vancouver

Narayanan R, Mohler ML, Bohl CE, Miller DD, Dalton JT. Selective androgen receptor modulators in preclinical and clinical development. Nuclear Receptor Signaling. 2008;6(1). doi:10.1621/nrs.06010

BibTeX
@article{Narayanan2008,
  author = {Narayanan, Ramesh and Mohler, Michael L and Bohl, Casey E and Miller, Duane D and Dalton, James T},
  title = {Selective androgen receptor modulators in preclinical and clinical development},
  journal = {Nuclear Receptor Signaling},
  year = {2008},
  volume = {6},
  number = {1},
  doi = {10.1621/nrs.06010}
}
Kostenlos starten →